It has been reported that abnormally expressed cyclin D1 was associated with multiple cancers, such as pancreatic cancer (41), non-small-cell lung carcinoma (42), breast cancer (43), head and neck squamous cell carcinoma (44), endometrial cancer (45), and colorectal carcinoma (46). Here, CCND1 is linked to colorectal carcinoma.